The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126540741 12654074 1 I 20160728 20160808 20160816 20160816 EXP US-ASTRAZENECA-2016SE86253 ASTRAZENECA 26892.00 DY F Y 76.70000 KG 20160816 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126540741 12654074 1 PS ARIMIDEX ANASTROZOLE 1 Oral 1.0MG UNKNOWN N U 20541 1 MG TABLET
126540741 12654074 2 SS FASLODEX FULVESTRANT 1 Intramuscular N U 0 INJECTION
126540741 12654074 3 SS LISINOPRIL. LISINOPRIL 1 Oral U 0 10 MG TABLET QD
126540741 12654074 4 SS LISINOPRIL. LISINOPRIL 1 Oral U 0 10 MG TABLET QD
126540741 12654074 5 SS TAMOXIFEN TAMOXIFEN 1 Oral 43240 MG U 0 20 MG TABLET QD
126540741 12654074 6 SS IBRANCE PALBOCICLIB 1 Unknown U U 0
126540741 12654074 7 C CYMBALTA DULOXETINE HYDROCHLORIDE 1 0 20 MG TABLET QD
126540741 12654074 8 C FENATYL FENTANYL 1 12 MCG, EVERY THREE YEARS 0 TRANSDERMAL PATCH
126540741 12654074 9 C LASIX FUROSEMIDE 1 Oral 0 20 MG TABLET QD
126540741 12654074 10 C NARCO 2 Oral 5/325 MG , ONE TABLET EVERY FOUR HOURS AS NEEDED 0 TABLET
126540741 12654074 11 C AROMASIN EXEMESTANE 1 0
126540741 12654074 12 C AFINITOR EVEROLIMUS 1 0
126540741 12654074 13 C AFINITOR EVEROLIMUS 1 0
126540741 12654074 14 C ADRIAMYCIN DOXORUBICIN HYDROCHLORIDE 1 0
126540741 12654074 15 C CYTOTOXIN 2 0
126540741 12654074 16 C AVASTIN BEVACIZUMAB 1 0
126540741 12654074 17 C FEMARA LETROZOLE 1 Oral 2.5MG UNKNOWN 0 2.5 MG TABLET
126540741 12654074 18 C AROMASIN EXEMESTANE 1 Oral 0 25 MG TABLET QD
126540741 12654074 19 C AFINITOR EVEROLIMUS 1 Oral 0 10 MG TABLET QD
126540741 12654074 20 C AFINITOR EVEROLIMUS 1 Oral 0 5 MG TABLET QD
126540741 12654074 21 C XELODA CAPECITABINE 1 0 2 DF TABLET BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126540741 12654074 1 Breast cancer female
126540741 12654074 2 Breast cancer female
126540741 12654074 3 Blood pressure abnormal
126540741 12654074 4 Cardiac failure congestive
126540741 12654074 6 Breast cancer female
126540741 12654074 7 Depression
126540741 12654074 8 Pain
126540741 12654074 9 Cardiac failure congestive
126540741 12654074 10 Pain

Outcome of event

Event ID CASEID OUTC COD
126540741 12654074 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126540741 12654074 Breast cancer female
126540741 12654074 Malignant neoplasm progression

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126540741 12654074 1 200212 200712 0
126540741 12654074 2 201111 201312 0
126540741 12654074 5 199701 200212 0
126540741 12654074 7 201109 0
126540741 12654074 8 201106 0
126540741 12654074 10 201106 0
126540741 12654074 11 201401 201405 0
126540741 12654074 12 201401 201402 0
126540741 12654074 13 201402 201405 0
126540741 12654074 14 1997 0
126540741 12654074 15 1997 0
126540741 12654074 17 201106 201110 0
126540741 12654074 18 201401 201405 0
126540741 12654074 19 201401 0
126540741 12654074 20 201405 0
126540741 12654074 21 201501 0